Remission doesn’t necessarily mean the patient is feeling well. Up to 74% of patients with IBD in remission continue to report symptoms, many of which significantly impair health-related quality of life.¹,† Beyond remission, which endpoints guide your long-term IBD care plan?
Lilly Gastroenterology
Verified account This account is verified because it's an official organization on X. Learn more@LillyGastroEU
Channel for the Professional Gastroenterology Community. Follow us for congress news, interviews & useful Gastro info. Guidelines: e.lilly/4bSHvqm
28 Following 1.9K Followers 172 Posts
Latest posts 5
Accumulating evidence indicates that microscopic activity persists in endoscopically quiescent UC.¹ Histological changes may lag behind clinical remission, increasing the risk of relapse.¹,² When the mucosa looks healed, how sure are you that the disease is under control?
0:30
Nearly 1 in 2 patients with IBD are suboptimally controlled.¹,† Clinical remission alone often fails to predict long-term remission or prevent complications.² Beyond symptoms, what outcomes are you prioritising to ensure long-term disease control?
0:31
Clinical remission in UC may not mean the risk of relapse has passed.¹ Up to ~30% of patients in clinical remission face a risk of relapse within 12 months.²,† What does disease control mean to you beyond resolution of symptoms?
Loss of response affects ~70% of patients with IBD. In your opinion, what sustains disease control? For HCPs, CMAT-59177. October 2026.
- Symptomatic remission 60
- Normal biomarkers 48
- Endoscopic healing 77
- Histologic healing 41